Cargando…

Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population

BACKGROUND: The PHQ-15 is widely used as an open access screening instrument for somatization syndromes in different health care settings, thus far, normative data from the general population are not available. The objectives of the study were to generate normative data and to further investigate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kocalevent, Rüya-Daniela, Hinz, Andreas, Brähler, Elmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606198/
https://www.ncbi.nlm.nih.gov/pubmed/23514436
http://dx.doi.org/10.1186/1471-244X-13-91
_version_ 1782263964967632896
author Kocalevent, Rüya-Daniela
Hinz, Andreas
Brähler, Elmar
author_facet Kocalevent, Rüya-Daniela
Hinz, Andreas
Brähler, Elmar
author_sort Kocalevent, Rüya-Daniela
collection PubMed
description BACKGROUND: The PHQ-15 is widely used as an open access screening instrument for somatization syndromes in different health care settings, thus far, normative data from the general population are not available. The objectives of the study were to generate normative data and to further investigate the construct validity of the PHQ-15 in the general population. METHODS: Nationally representative face-to face household surveys were conducted in Germany between 2003 and 2008 (n=5,031). The survey questionnaires included, the 15-item somatization module from the Patient Health Questionnaire (PHQ-15), the 9-item depression module (PHQ-9), the Satisfaction With Life Scale (SWLS), the SF-12 for the measurement of health related quality of life, and demographic characteristics. RESULTS: Normative data for the PHQ-15 were generated for both genders and different age levels including 5031 subjects (53.6% female) with a mean age (SD) of 48.9 (18.1) years. Somatization syndromes occured in 9.3% of the general population. Women had significantly higher mean (SD) scores compared with men [4.3 (4.1) vs. 3.4 (4.0)]. Intercorrelations with somatization were highest with depression, followed by the physical component summary scale of health related quality of life. CONCLUSIONS: The normative data provide a framework for the interpretation and comparisons of somatization syndromes with other populations. Evidence supports reliability and validity of the PHQ-15 as a measure of somatization syndromes in the general population.
format Online
Article
Text
id pubmed-3606198
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36061982013-03-23 Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population Kocalevent, Rüya-Daniela Hinz, Andreas Brähler, Elmar BMC Psychiatry Research Article BACKGROUND: The PHQ-15 is widely used as an open access screening instrument for somatization syndromes in different health care settings, thus far, normative data from the general population are not available. The objectives of the study were to generate normative data and to further investigate the construct validity of the PHQ-15 in the general population. METHODS: Nationally representative face-to face household surveys were conducted in Germany between 2003 and 2008 (n=5,031). The survey questionnaires included, the 15-item somatization module from the Patient Health Questionnaire (PHQ-15), the 9-item depression module (PHQ-9), the Satisfaction With Life Scale (SWLS), the SF-12 for the measurement of health related quality of life, and demographic characteristics. RESULTS: Normative data for the PHQ-15 were generated for both genders and different age levels including 5031 subjects (53.6% female) with a mean age (SD) of 48.9 (18.1) years. Somatization syndromes occured in 9.3% of the general population. Women had significantly higher mean (SD) scores compared with men [4.3 (4.1) vs. 3.4 (4.0)]. Intercorrelations with somatization were highest with depression, followed by the physical component summary scale of health related quality of life. CONCLUSIONS: The normative data provide a framework for the interpretation and comparisons of somatization syndromes with other populations. Evidence supports reliability and validity of the PHQ-15 as a measure of somatization syndromes in the general population. BioMed Central 2013-03-20 /pmc/articles/PMC3606198/ /pubmed/23514436 http://dx.doi.org/10.1186/1471-244X-13-91 Text en Copyright ©2013 Kocalevent et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kocalevent, Rüya-Daniela
Hinz, Andreas
Brähler, Elmar
Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population
title Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population
title_full Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population
title_fullStr Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population
title_full_unstemmed Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population
title_short Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population
title_sort standardization of a screening instrument (phq-15) for somatization syndromes in the general population
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606198/
https://www.ncbi.nlm.nih.gov/pubmed/23514436
http://dx.doi.org/10.1186/1471-244X-13-91
work_keys_str_mv AT kocaleventruyadaniela standardizationofascreeninginstrumentphq15forsomatizationsyndromesinthegeneralpopulation
AT hinzandreas standardizationofascreeninginstrumentphq15forsomatizationsyndromesinthegeneralpopulation
AT brahlerelmar standardizationofascreeninginstrumentphq15forsomatizationsyndromesinthegeneralpopulation